
    
      This study is a prospective, single arm, pre-approval study. Treatment of up to 92 patients
      will take place at up to 15 clinical centers. Patient who meet all eligibility criteria will
      receive the WallFlex Pancreatic stent for up to 6 months stent indwell and 6 months follow-up
      after stent removal.
    
  